Details for New Drug Application (NDA): 011011
✉ Email this page to a colleague
NDA 011011 describes ROBAXIN-750, which is a drug marketed by Endo Operations and is included in one NDA. Additional details are available on the ROBAXIN-750 profile page.
The generic ingredient in ROBAXIN-750 is methocarbamol. There are twenty-seven drug master file entries for this compound. Sixty-two suppliers are listed for this compound. Additional details are available on the methocarbamol profile page.
The generic ingredient in ROBAXIN-750 is methocarbamol. There are twenty-seven drug master file entries for this compound. Sixty-two suppliers are listed for this compound. Additional details are available on the methocarbamol profile page.
Summary for 011011
| Tradename: | ROBAXIN-750 |
| Applicant: | Endo Operations |
| Ingredient: | methocarbamol |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 011011
Profile for product number 004
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Profile for product number 006
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 750MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
